In:
Clinical Medicine Insights: Oncology, SAGE Publications, Vol. 14 ( 2020-01), p. 117955492097969-
Abstract:
Immunotherapy, as a novel treatment, has brought new hope to many patients with cancer, including patients with lung cancer. However, the overall cure rate and survival rate of lung cancer are still not satisfactory. The process of evolution has improved the ability of tumors to adapt to immunotherapy, which induces drug resistance. Many studies have focused on immunoresistance and achieved meaningful results. Therefore, it is necessary to have an in-depth understanding of the current research progress in immunoresistance, which will help to achieve good clinical results more efficiently.
Type of Medium:
Online Resource
ISSN:
1179-5549
,
1179-5549
DOI:
10.1177/1179554920979697
Language:
English
Publisher:
SAGE Publications
Publication Date:
2020
detail.hit.zdb_id:
2577877-8